• Deferasirox Fe3+ Chelate: Mechanism, Evidence, and Research

  2026-05-13

  Deferasirox Fe3+ chelate (Exjade) is a high-purity oral iron chelator widely used in iron overload treatment research. It binds ferric iron (Fe3+) with high specificity, facilitating excretion and preventing iron-induced organ toxicity. APExBIO supplies this compound for research use, supporting studies in chronic anemia and beta-thalassemia models.

• Biomimetic Microparticles Disrupt Tumor pH for Chemo-Immunot

  2026-05-13

  This study presents a biomimetic microparticle system designed to simultaneously disrupt both intracellular and extracellular pH homeostasis in tumor cells by co-delivering syrosingopine and a doxorubicin prodrug. The approach leverages lactate export inhibition and pH-dependent drug activation to enhance both chemotherapy and immunotherapy efficacy, offering a promising strategy against tumor immune evasion.

• Angiotensin 1/2 (5-7): Bridging Hypertension and Viral Entry

  2026-05-12

  This article delivers a thought-leadership perspective on Angiotensin 1/2 (5-7), a precision peptide at the nexus of cardiovascular and infectious disease research. Translational investigators will gain mechanistic clarity, strategic protocol guidance, and an evidence-driven view of how this H2N-Ile-His-Pro-OH peptide is redefining the research landscape—particularly with respect to the renin-angiotensin system, hypertension models, and SARS-CoV-2 pathogenesis. Leveraging insights from recent peer-reviewed work, as well as APExBIO’s product quality, this piece offers a roadmap for rigorous, cross-domain investigation.

• JC-1 Mitochondrial Membrane Potential Assay Kit: Applied Ins

  2026-05-12

  The JC-1 Mitochondrial Membrane Potential Assay Kit empowers researchers to quantitatively assess mitochondrial health and apoptosis in diverse experimental settings. Its robust, ratiometric workflow, built-in positive control, and compatibility with advanced immunomodulatory studies make it a go-to solution for translational and drug discovery labs.

• Angiotensin II Induces M1 Macrophage Polarization via Cx43/N

  2026-05-11

  This study elucidates the mechanistic pathway by which Angiotensin II drives RAW264.7 macrophage polarization toward the pro-inflammatory M1 phenotype through Connexin 43 and NF-κB signaling. The findings clarify the inflammatory roles of Angiotensin II in vascular disease models and provide a molecular basis for targeting macrophage polarization in cardiovascular research.

• PP 3: A Rigorously Validated Negative Control in Src Kinase

  2026-05-11

  PP 3 (1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine) is a research use only chemical that serves as a negative control for Src kinase inhibitor PP 2, enabling precise validation of kinase pathway specificity. Supplied by APExBIO (SKU B7190), it supports robust experimental design in Src kinase signaling pathway research.

• ICG001: Applied Use of a Wnt/β-Catenin Pathway Inhibitor in

  2026-05-10

  ICG001 enables precise modulation of Wnt/β-catenin signaling, powering advanced experimental workflows in EMT and fibrosis research. Explore protocol-driven insights, troubleshooting strategies, and translational use-cases for dissecting CBP/β-catenin interactions with APExBIO’s trusted reagent.

• Canagliflozin as an SGLT2 Inhibitor: Workflow Innovations in

  2026-05-09

  Canagliflozin, a potent SGLT2 inhibitor from APExBIO, empowers diabetes and renal researchers to probe beyond glucose lowering—enabling advanced mitochondrial and kidney-protective assays. This guide translates recent mechanistic discoveries into actionable protocol enhancements, troubleshooting insights, and practical parameters for metabolic disease models.

• AMD-070 Hydrochloride: Applied Workflows with CXCR4 Antagoni

  2026-05-08

  Mavorixafor hydrochloride (AMD-070 hydrochloride) enables translational researchers to precisely modulate the CXCR4 signaling axis across rare immunodeficiencies and anti-HIV models. This article breaks down protocol design, troubleshooting, and integration strategies for leveraging this potent, oral CXCR4 antagonist from APExBIO, grounded in the latest clinical and workflow evidence.

• MLN8237 (Alisertib) in Trained Immunity and Tumor Progressio

  2026-05-08

  Explore how MLN8237 (Alisertib), a selective Aurora A kinase inhibitor, uniquely modulates trained immunity and tumor biology. This article delivers a deeper scientific perspective on epigenetic and metabolic mechanisms, distinguishing itself from protocol-focused resources.

• GLP-1 (9-36) amide: Precision Antagonist for GLP-1R Research

  2026-05-07

  GLP-1 (9-36) amide is a rigorously validated peptide antagonist of the human GLP-1 receptor, supporting high-specificity investigations in metabolic regulation and type 2 diabetes research. This article details its mechanism, evidence base, and protocol integration, emphasizing its critical role in dissecting GLP-1 receptor signaling.

• Bradykinin (BA5201): Technical Guidance for Lab Researchers

  2026-05-07

  Bradykinin (SKU BA5201) is an endothelium-dependent vasodilator peptide widely used to model vascular permeability, smooth muscle contraction, and pain/inflammation pathways in controlled research settings. This product is suitable for in vitro and ex vivo assay workflows requiring reliable, rapid vasodilator responses. It should not be used for diagnostic or clinical applications.

• DCPS as an m7G Biomarker in Diabetic Foot Ulcer Healing

  2026-05-06

  This study identifies the decapping scavenger enzyme (DCPS), an m7G-related gene, as a novel biomarker and regulator of epithelial cell function in diabetic foot ulcers (DFU). Using integrated transcriptomic, functional, and cell cycle analyses, the authors demonstrate DCPS’s role in modulating cell proliferation and migration, offering new insight for wound healing research and biomarker-driven therapeutic strategies.

• Adipose-Neural Axis Drives Arrhythmias via Leptin-NPY Pathwa

  2026-05-06

  Fan et al. (2024) establish a mechanistic link between epicardial adipose tissue, sympathetic neural activation, and cardiac arrhythmias using an advanced co-culture model. Their findings highlight the leptin–NPY axis as a key driver of arrhythmogenesis and nominate molecular targets for future intervention.

• 5-(N,N-dimethyl)-Amiloride Hydrochloride: Precision Tools fo

  2026-05-05

  Explore how 5-(N,N-dimethyl)-Amiloride hydrochloride enables advanced, quantitative dissection of endothelial ion transport, intracellular pH regulation, and cellular injury in sepsis models. This article offers a novel assay-design perspective, connecting practical protocol decisions to recent biomarker discoveries.

16174 records 1/1079 page Next 12345 下5页 Last page